Common medications trigger Alzheimer's, researchers find

Share this article:


Certain widely prescribed medications can trigger or slow the progress of Alzheimer's disease, according to recently published research.
 
A Mount Sinai Medical Center team screened 1,600 FDA-approved medications, using a computer algorithm to determine which drugs are associated with blocking or stimulating beta amyloid accumulation. Amyloid plaques build up in the brains of Alzheimer's patients.
 
 
Of the screened drugs, 800 reduced amyloid beta content more than 10% in primary neurons from mice, the researchers found. About 240 drugs promoted amyloid beta. 
 
While many classes of drugs were found to impact amyloid beta production, the researchers focused especially on those used to treat cardiovascular conditions. Certain blood pressure medications, such as propranolol (Inderal) and nicardipine (Cardene), reduced amyloid beta production, while drugs including furosemide (Lasix) had the opposite effect. Experiments with mice confirmed that some CV medications, particularly carvedilol (Coreg), hold promise as Alzheimer's drugs.
 

“This line of investigation will lead to the identification of common medications that are potentially beneficial or detrimental to [Alzheimer's disease] as a reference for physicians to consider when prescribing the most appropriate drugs for their patients, particularly for treating chronic disorders among the growing geriatric population,” the researchers wrote.

 
The complete findings were published online in the journal PLoS One .
Share this article:

More in News

Also in the news for August 22, 2014

Iowa's nursing homes lost, on average, 41% of their employees each year from 2010-2012 ... Researchers identify proteins necessary in wound healing ... More than 40% percent of SSDI recipients take opioid pain relievers, study says.

CMS: Many skilled nursing providers have poor Medicare certification and recertification practices

CMS: Many skilled nursing providers have poor Medicare ...

The rate of improper Medicare payments to skilled nursing facilities has increased largely due to issues with certification and recertification statements, according to a recently released government memorandum. The Centers ...

NY nursing home agrees to $2.2 million settlement in case of false documentation

NY nursing home agrees to $2.2 million settlement ...

Nursing home operator Ralex Services Inc. has agreed to a $2.2 million settlement in a whistleblower case involving forged documents at a facility in New Rochelle, New York.